ONC vs REGN

BeOne Medicines AG and Regeneron Pharmaceuticals, both Healthcare

Regeneron Pharmaceuticals is the larger company at $98B against $46B. Over the past year REGN returned +45% against +23% for ONC.

BeOne Medicines AG and Regeneron Pharmaceuticals compared on valuation multiples, growth, margins and return
FigureONCREGN
Last close$404$945
Market cap$46B$98B
Trailing P/En/a20.9
Revenue growthn/a+19%
Operating marginn/a29%
Net marginn/a29%
Free cash flow yieldn/a3.9%
Net cashn/a$7.3B
Insiders, 12 monthssold $392M netsold $58M net
1-year return+23%+45%
5-year return+8.0%+46%

Figures from SEC filings and end-of-day closes. Highlighting marks the higher number in each row, nothing more.

BeOne Medicines AG

Regeneron Pharmaceuticals

Revenue of $5.1B in the quarter to Sep 30, 2026, net income $1.9B. Its largest reported line is Share Of Profit (Losses), 50% of the disclosed total.

Open these two in the interactive comparison to add more names, change the period or see the correlation.